| 1 |
35062878 | A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation. | 2022 Jan 21 |
1 |
| 2 |
31699808 | Assessment and Confirmation of Species Difference in Nonlinear Pharmacokinetics of Atipamezole with Physiologically Based Pharmacokinetic Modeling. | 2020 Jan |
1 |
| 3 |
29438977 | Post-transcriptional Regulation of UGT2B10 Hepatic Expression and Activity by Alternative Splicing. | 2018 May |
1 |
| 4 |
29691239 | Disposition of Mianserin and Cyclizine in UGT2B10-Overexpressing Human Embryonic Kidney 293 Cells: Identification of UGT2B10 as a Novel N-Glucosidation Enzyme and Breast Cancer Resistance Protein as an N-Glucoside Transporter. | 2018 Jul |
2 |
| 5 |
30049229 | Highly selective N-glucuronidation of four piperazine-containing drugs by UDP-glucuronosyltransferase 2B10. | 2018 Sep |
3 |
| 6 |
28803208 | N-glucuronidation catalyzed by UGT1A4 and UGT2B10 in human liver microsomes: Assay optimization and substrate identification. | 2017 Oct 25 |
5 |
| 7 |
26669329 | Human UDP-Glucuronosyltransferase (UGT) 2B10: Validation of Cotinine as a Selective Probe Substrate, Inhibition by UGT Enzyme-Selective Inhibitors and Antidepressant and Antipsychotic Drugs, and Structural Determinants of Enzyme Inhibition. | 2016 Mar |
1 |
| 8 |
25503386 | A UGT2B10 splicing polymorphism common in african populations may greatly increase drug exposure. | 2015 Feb |
1 |
| 9 |
26135009 | Further Characterization of the Metabolism of Desloratadine and Its Cytochrome P450 and UDP-glucuronosyltransferase Inhibition Potential: Identification of Desloratadine as a Relatively Selective UGT2B10 Inhibitor. | 2015 Sep |
1 |
| 10 |
25233931 | Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups. | 2014 Nov |
3 |
| 11 |
23611809 | Human UDP-glucuronosyltransferase (UGT) 2B10 in drug N-glucuronidation: substrate screening and comparison with UGT1A3 and UGT1A4. | 2013 Jul |
4 |
| 12 |
21434773 | N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases. | 2011 Aug |
3 |
| 13 |
20133892 | Role of human UGT2B10 in N-glucuronidation of tricyclic antidepressants, amitriptyline, imipramine, clomipramine, and trimipramine. | 2010 May |
2 |
| 14 |
18238858 | Glucuronidation of tobacco-specific nitrosamines by UGT2B10. | 2008 May |
1 |
| 15 |
18474681 | Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes. | 2008 Aug |
1 |
| 16 |
17576790 | Nicotine glucuronidation and the human UDP-glucuronosyltransferase UGT2B10. | 2007 Sep |
2 |
| 17 |
17909004 | Glucuronidation of nicotine and cotinine by UGT2B10: loss of function by the UGT2B10 Codon 67 (Asp>Tyr) polymorphism. | 2007 Oct 1 |
4 |